Home › NDC Lookup › RxCUI directory › RxCUI 1743722

Methylprednisolone 500 MG Injection [Solu-Medrol] — RxCUI 1743722

RxNorm drug concept · Semantic branded drug
RxCUI 1743722 Semantic branded drug · SBD ● Current RxNorm concept 7 FDA products 9 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1743722
Official nameMethylprednisolone 500 MG Injection [Solu-Medrol]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asSolu-Medrol 500 MG Injection; Solu-Medrol (as methylprednisolone sodium succinate) 500 MG Injection
FDA products mapped7
Package NDCs mapped9
Reported Medicaid activity (SDUD)121,368 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Methylprednisolone Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Methylprednisolone injection covers a really wide range. Depending on where it's injected, it can treat severe allergic reactions, flare-ups of rheumatoid arthritis or lupus, infla...
  • What kinds of conditions is this injection used for?
  • Yes — corticosteroids like methylprednisolone do suppress the immune system, which is actually part of how they reduce inflammation. But it does mean you're more vulnerable to infe...
  • Will this injection affect my immune system? Should I avoid sick people?
📖 Read our full Methylprednisolone Injection guide →

🕸️ Concept Web — How Methylprednisolone 500 MG Injection [Solu-Medrol... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Methylprednisolone 500 MG Injection [Solu-Medrol] RxCUI 1743722

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Methylprednisolone 6902
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Solu-Medrol 203856
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Methylprednisolone Injection 1743703
    • Methylprednisolone Injectable Product 1163486
    • Methylprednisolone Injection [Solu-Medrol] 1743706
    • Solu-Medrol Injectable Product 1184840
    • Injection 1649574
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Methylprednisolone 500 MG Injection SCD · 1743720
  • Methylprednisolone 500 MG SCDC · 1743719
  • Methylprednisolone Injection SCDF · 1743703
  • Methylprednisolone Injectable Product SCDG · 1163486

Brand-Name Concepts

  • Methylprednisolone 500 MG [Solu-Medrol] SBDC · 1743721
  • Methylprednisolone Injection [Solu-Medrol] SBDF · 1743706
  • Solu-Medrol Injectable Product SBDG · 1184840
  • Solu-Medrol BN · 203856

📦 FDA Products & Package NDCs

7 products · 9 package NDCs
9 package NDCs map to RxCUI 1743722 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00009-0003-02 1 VIAL in 1 CARTON (0009-0003-02) / 4 mL in 1 VIAL SOLU-MEDROL Pharmacia & Upjohn Company LLC 1959-04-02
00009-0018-20 1 VIAL in 1 CARTON (0009-0018-20) / 8 mL in 1 VIAL SOLU-MEDROL Pharmacia & Upjohn Company LLC 1959-04-02
00009-0039-28 25 VIAL in 1 CARTON (0009-0039-28) / 1 mL in 1 VIAL (0009-0... SOLU-MEDROL Pharmacia & Upjohn Company LLC 1959-04-02
00009-0039-32 25 VIAL in 1 CARTON (0009-0039-32) / 1 mL in 1 VIAL (0009-0... SOLU-MEDROL Pharmacia & Upjohn Company LLC 1959-04-02
00009-0047-22 25 VIAL in 1 CARTON (0009-0047-22) / 2 mL in 1 VIAL (0009-0... SOLU-MEDROL Pharmacia & Upjohn Company LLC 1959-04-02
00009-0047-26 25 VIAL in 1 CARTON (0009-0047-26) / 2 mL in 1 VIAL (0009-0... SOLU-MEDROL Pharmacia & Upjohn Company LLC 1959-04-02
00009-0698-01 1 VIAL in 1 CARTON (0009-0698-01) / 16 mL in 1 VIAL SOLU-MEDROL Pharmacia & Upjohn Company LLC 1959-04-02
00009-0758-01 1 VIAL in 1 CARTON (0009-0758-01) / 8 mL in 1 VIAL SOLU-MEDROL Pharmacia & Upjohn Company LLC 1959-04-02
00009-0850-01 1 VIAL in 1 CARTON (0009-0850-01) / 30.6 mL in 1 VIAL SOLU-MEDROL Pharmacia & Upjohn Company LLC 2019-12-06
Observed labelers: Pharmacia & Upjohn Company LLC (9) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J2919 Inj, methylpred sod succ 5mg 9 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.